The bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein – present in the original Pfizer/BioNTech COVID-19 vaccine – together with mRNA encoding the spike protein of the Omicron BA.4/BA.5 subvariants. The booster has already been granted EUA by the FDA for ages 12 years and older.
The doses will be shipped immediately, pending recommendation from the Centers for Disease Control and Prevention (CDC), the companies outlined in a statement.